Raltegravir potassium
potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate
Molecular Identity
Raltegravir potassium
potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate
PubChem CID: 23668479
2D Structure
Properties
C20H20FKN6O5
Molecular Formula
482.50
Molecular Weight
g/mol
482.1116
Exact Mass
Da
153
TPSA
May have limited oral absorption
2
H-Bond Donors
9
H-Bond Acceptors
843
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Raltegravir potassium871038-72-1Raltegravir Potassium SaltIsentressMK0518 POTASSIUMMK-0518 POTASSIUMRaltegravir monopotassium salt43Y000U234Isentress hdL000900612 POTASSIUM SALTL-000900612 POTASSIUM SALTDUTREBIS COMPONENT RALTEGRAVIR POTASSIUMN-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide monopotassium saltPotassium, RaltegravirRefChem:55965
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Raltegravir potassium
Loading drug network...